Evolving role of skin sparing mastectomy

doi:10.5306/wjco.v5.i2.33

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4525)

All Articles published online

The chart showing PDF series, WORD series, HTML series.

Item

Count

PDF

320

WORD

209

HTML

2341

Sum=2870

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

857

Download

798

Sum=1655

May 10, 2014 (publication date) through May 12, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Clin Oncol. May 10, 2014; 5(2): 33-35
Published online May 10, 2014. doi: 10.5306/wjco.v5.i2.33

Evolving role of skin sparing mastectomy

Abdul Kasem, Kefah Mokbel

Abdul Kasem, Kefah Mokbel, London Breast Institute, Princess Grace Hospital, London, W1U 5NY, United Kingdom

Author contributions: Both authors equally contributed to the paper.

Correspondence to: Kefah Mokbel, Professor, London Breast Institute, Princess Grace Hospital, 42-52 Nottingham Place, London, W1U 5NY, United Kingdom. kefahmokbel@hotmail.com

Telephone: +44-207-9082040 Fax: +44-207-9082275

Received: November 9, 2013
Revised: February 20, 2014
Accepted: March 13, 2014
Published online: May 10, 2014

Core Tip

Core tip: Skin sparing mastectomy (SSM) is oncologically safe in selected cases and is aesthetically superior to simple mastectomy. New techniques such as the use of acellular dermal matrix a and cell-assisted fat transfer have enhanced the use of implants for volume replacement following SSM.